REG - Competition and Mkts - Merger Update: Cochlear / Oticon

Demant A/SAnnouncement

17/11/2022 08:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221117:nRSQ6623Ga&default-theme=true

RNS Number : 6623G  Competition and Markets Authority  17 November 2022

 

 

Initial Enforcement Order

 

The CMA has served an initial enforcement order under section 72(2) of the
Enterprise Act 2002 to Demant A/S and its Oticon Medical subsidiaries on 14
November 2022, in relation to the anticipated acquisition by Cochlear Limited
of the hearing implants business of Demant A/S, known as Oticon Medical.

 

The text of the order has been published on the Competition and Markets
Authority's website at https://www.gov.uk/cma-cases
(https://www.gov.uk/cma-cases) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MERBKABPNBDDCDD